Where is Vedanta headquartered?

Vedanta is located in Cambridge, MA.

Who invested in Vedanta?

Vedanta has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Vedanta?

Vedanta closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

vedantabio.com

Vedanta

Vedanta is a Massachusetts-based biotechnology company that develops and commercializes novel therapies for the treatment of immune-mediated inflammatory diseases.

Business Model:

Revenue: $8M

Employees: 51-200

Geographic Data

Address: 19 Blackstone Street

City: Cambridge

State: MA

Zip: 02139

Country: US

Financial Info

Stage:

series d

Raised Last:

$43M

Raised Total:

$302M

Social

Twitter

Crunchbase

Metrics

3,359,247Website Global Rank

4,413Website Monthly Traffic

Twitter Followers

Description

Vedanta is a Massachusetts-based biotechnology company that develops and commercializes novel therapies for the treatment of immune-mediated inflammatory diseases.

Contact Phone:
+18577061427

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
12/2019	Grant	1	$5.8M	CARB-X CARB-X
7/2021	Series D		$68.4M	Verition Fund Management Fosun Health Capital Rock Springs Capital Skyviews Life Science JSR Corporation SymBiosis LLC Shumway Capital Health for Life Capital
12/2018	Series C		$0	PureTech Health Seventure Partners Rock Springs Capital Invesco Asset Management Bristol Myers Squibb Bill &a; Melinda Gates Foundation PureTech Health Seventure Partners Rock Springs Capital Invesco Asset Management Bristol Myers Squibb Bill &a; Melinda Gates Foundation
6/2013	Venture Round	1	-	Johnson &a; Johnson Development Corporation Johnson &a; Johnson Development Corporation
5/2019	Series C	4	$18.5M	Shumway Capital Symbiosis Group Partners Investment JSR Corp
9/2020	Grant	1	$76.9M	Biomedical Advanced Research and Development Authority (BARDA) Biomedical Advanced Research and Development Authority (BARDA)
9/2020	Debt Financing	1	$15M	Oxford Finance LLC
1/2021	Venture Round	1	$25M	Pfizer Breakthrough Growth Initiative Pfizer Breakthrough Growth Initiative
12/2010	Seed Round		-
6/2016	Private Equity Round		$0	PureTech Health Rock Springs Capital Invesco PureTech Health Rock Springs Capital Invesco
9/2019	Series C	6	$16.6M	FC Capital Partners Investment QUAD Investment Management Shinhan Capital Shinhan Private Equity SV Investment Corp
11/2017	Grant	1	$5.4M	CARB-X CARB-X
4/2023	Series E		$0	AMR Action Fund Atlantic Neptune AXA Investment Managers Bill &a; Melinda Gates Foundation Fiscus Ventures Hambro Perks Ltd. K2 HealthVentures KOREA INVESTMENT &a; SECURITIES Korea Investment Holdings Korea Investment Partners Peak 6 Pfizer PureTech Health QUAD Investment Management Reimagined Ventures Revelation Partners Seventure Partners Skyviews Life Science AMR Action Fund Atlantic Neptune AXA Investment Managers Bill &a; Melinda Gates Foundation Fiscus Ventures Hambro Perks Ltd. K2 HealthVentures KOREA INVESTMENT &a; SECURITIES Korea Investment Holdings Korea Investment Partners Peak 6 Pfizer PureTech Health QUAD Investment Management Reimagined Ventures Revelation Partners Seventure Partners Skyviews Life Science AMR Action Fund Atlantic Neptune AXA Investment Managers Bill &a; Melinda Gates Foundation Fiscus Ventures Hambro Perks Ltd. K2 HealthVentures KOREA INVESTMENT &a; SECURITIES Korea Investment Holdings Korea Investment Partners Peak 6 Pfizer PureTech Health QUAD Investment Management Reimagined Ventures Revelation Partners Seventure Partners Skyviews Life Science AMR Action Fund Atlantic Neptune AXA Investment Managers Bill &a; Melinda Gates Foundation Fiscus Ventures Hambro Perks Ltd. K2 HealthVentures KOREA INVESTMENT &a; SECURITIES Korea Investment Holdings Korea Investment Partners Peak 6 Pfizer PureTech Health QUAD Investment Management Reimagined Ventures Revelation Partners Seventure Partners Skyviews Life Science
7/2021	Series D		$0	Health for Life Capital fund JSR Magnetar Capital PureTech Health Rock Springs Capital Shumway Capital Skyviews Life Science SymBiosis LLC Verition Fund Management Health for Life Capital fund JSR Magnetar Capital PureTech Health Rock Springs Capital Shumway Capital Skyviews Life Science SymBiosis LLC Verition Fund Management
7/2018	Grant	1	-	Crohn&s;s &a; Colitis UK Crohn&s;s &a; Colitis UK
1/2021	Secondary Market	1	-	Hambro Perks Ltd. Hambro Perks Ltd.
7/2021	Series D	9	$43M	Health for Life Capital fund JSR Corp Magnetar Capital PureTech Health Rock Springs Capital Shumway Capital Skyviews Life Science SymBiosis LLC Verition Fund Management Health for Life Capital fund JSR Corp Magnetar Capital PureTech Health Rock Springs Capital Shumway Capital Skyviews Life Science SymBiosis LLC Verition Fund Management
1/2021	Secondary Market	1	-	Hambro Perks Ltd. Hambro Perks Ltd.
12/2018	Series C	6	$45.4M
7/2018	Grant	1	-	Crohn&s;s &a; Colitis UK Crohn&s;s &a; Colitis UK

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details